The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

VCU’s Baskin and UNC’s Ferris weigh oncology’s looming dilemma—MCDs
Center directors are strategizing for likely FDA approval of GRAIL’s Galleri

Cancer Policy

Letai announces: NCI met FY26 goal of full funding payout

FDA launches Rare Disease Framework Initiative for drug development

FDA seeks nominations for the Tobacco Products Scientific Advisory Committee, announces new members

HHS plans agency-wide vaccine injury programs

One million never-smokers are now vaping in the UK, survey finds

Trump administration sends Medicare beneficiaries $90 checks ahead of midterm elections

Clinical Roundup

UCLA scientists identify clues to making immunotherapy more effective against glioblastoma

Wistar Institute study identifies immunotherapy strategy for glioblastoma

ACS studies find widening rural-urban survival and mortality gaps for women with breast cancer

ChristianaCare study identifies potential drug combination for making CRC more responsive to retinoids

NCCN publishes guidelines for pediatric Ewing sarcoma

Number of patients oncologists treated with cell and gene therapy has doubled, physician survey finds

In The Clinic

Cancer vaccine policy in limbo as CDC keeps canceling advisory meetings

Regulatory News
FreeGuest Editorial
Guest Editorial

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account